You can:
Name | P2Y purinoceptor 2 |
---|---|
Species | Homo sapiens (Human) |
Gene | P2RY2 |
Synonym | Purinergic receptor purinergic receptor P2Y P2Y2 receptor P2Y2 P2Y purinoceptor 2 [ Show all ] |
Disease | Dry eye disease Constipation Cystic fibrosis Lung cancer |
Length | 377 |
Amino acid sequence | MAADLGPWNDTINGTWDGDELGYRCRFNEDFKYVLLPVSYGVVCVPGLCLNAVALYIFLCRLKTWNASTTYMFHLAVSDALYAASLPLLVYYYARGDHWPFSTVLCKLVRFLFYTNLYCSILFLTCISVHRCLGVLRPLRSLRWGRARYARRVAGAVWVLVLACQAPVLYFVTTSARGGRVTCHDTSAPELFSRFVAYSSVMLGLLFAVPFAVILVCYVLMARRLLKPAYGTSGGLPRAKRKSVRTIAVVLAVFALCFLPFHVTRTLYYSFRSLDLSCHTLNAINMAYKVTRPLASANSCLDPVLYFLAGQRLVRFARDAKPPTGPSPATPARRRLGLRRSDRTDMQRIEDVLGSSEDSRRTESTPAGSENTKDIRL |
UniProt | P41231 |
Protein Data Bank | N/A |
GPCR-HGmod model | P41231 |
3D structure model | This predicted structure model is from GPCR-EXP P41231. |
BioLiP | N/A |
Therapeutic Target Database | T93515 |
ChEMBL | CHEMBL4398 |
IUPHAR | 324 |
DrugBank | BE0002401 |
Name | Adenosine triphosphate |
---|---|
Molecular formula | C10H16N5O13P3 |
IUPAC name | [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate |
Molecular weight | 507.181 |
Hydrogen bond acceptor | 17 |
Hydrogen bond donor | 7 |
XlogP | -5.7 |
Synonyms | 1r0x CHEBI:15422 DB-022415 51569-41-6 Epitope ID:135612 [ Show all ] |
Inchi Key | ZKHQWZAMYRWXGA-KQYNXXCUSA-N |
Inchi ID | InChI=1S/C10H16N5O13P3/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(26-10)1-25-30(21,22)28-31(23,24)27-29(18,19)20/h2-4,6-7,10,16-17H,1H2,(H,21,22)(H,23,24)(H2,11,12,13)(H2,18,19,20)/t4-,6-,7-,10-/m1/s1 |
PubChem CID | 5957 |
ChEMBL | CHEMBL14249 |
IUPHAR | 1713 |
BindingDB | 2, 50366480 |
DrugBank | DB00171 |
Structure | |
Lipinski's druglikeness | This ligand has more than 5 hydrogen bond donor. This ligand has more than 10 hydrogen bond acceptor. This ligand is heavier than 500 daltons. |
Parameter | Value | Reference | Database source |
---|---|---|---|
EC50 | <300000.0 nM | PMID19419204 | ChEMBL |
EC50 | 30.1 nM | PMID19419204 | ChEMBL |
EC50 | 63.1 nM | PMID19419204 | BindingDB,ChEMBL |
EC50 | 79.4328 - 229.087 nM | PMID8564228, PMID11754592, PMID12213051 | IUPHAR |
EC50 | 85.0 nM | PMID11985476, PMID19419868, PMID17302398 | BindingDB,ChEMBL |
EC50 | 95.8 nM | PMID19419204 | BindingDB,ChEMBL |
EC50 | 111.0 nM | PMID19419204 | ChEMBL |
EC50 | 120.0 nM | PMID19419204 | ChEMBL |
EC50 | 183.0 nM | PMID19419204 | ChEMBL |
EC50 | 230.0 nM | PMID12213051 | BindingDB,ChEMBL |
EC50 | 237.0 nM | PMID19419204 | ChEMBL |
EC50 | 239.0 nM | PMID19419204 | ChEMBL |
EC50 | 299.0 nM | PMID19419204 | ChEMBL |
EC50 | 1000.0 nM | PMID19419204 | ChEMBL |
EC50 | 11700.0 nM | PMID19419204 | ChEMBL |
Efficacy | 5.0 % | PMID19419204 | ChEMBL |
Efficacy | 41.0 % | PMID19419204 | ChEMBL |
Efficacy | 87.0 % | PMID19419204 | ChEMBL |
Efficacy | 92.0 % | PMID19419204 | ChEMBL |
Efficacy | 97.0 % | PMID19419204 | ChEMBL |
Efficacy | 104.0 % | PMID19419204 | ChEMBL |
Efficacy | 110.0 % | PMID19419204 | ChEMBL |
Efficacy | 115.0 % | PMID19419204 | ChEMBL |
Efficacy | 117.0 % | PMID19419204 | ChEMBL |
Efficacy | 126.0 % | PMID19419204 | ChEMBL |
Efficacy | 130.0 % | PMID19419204 | ChEMBL |
Ratio EC50 | 2.0 - | PMID19419204 | ChEMBL |
Ratio EC50 | 3.0 - | PMID19419204 | ChEMBL |
Ratio EC50 | 4.0 - | PMID19419204 | ChEMBL |
Ratio EC50 | 10.0 - | PMID19419204 | ChEMBL |
zhanglabzhanggroup.org | +65-6601-1241 | Computing 1, 13 Computing Drive, Singapore 117417